Skip to main navigation

News

Overview
Events & Presentations
Stock Information
- Stock Quote & Chart
- Historic Stock Lookup
- Analyst Coverage
Press Releases
Corporate Governance
- Committee Composition
- IRS – Required Disclosures
Financials
- SEC Filings
- Quarterly Results
- Annual Reports & Proxy
State Compliance
Contact
Email Alerts
FAQs

Careers

Contacts

About Us
Patients & Caregivers
Our Products
Our Pipeline
News
Investors
Careers
Contacts

Event Details

Zevra Therapeutics Q3 2026 Earnings Call

11/03/2026 | 4:30 PM EST

Listen to webcast

Add to Outlook

Add to Google Calendar

About Us

Our Mission & Vision The Zevra Story Leadership Board of Directors What We Do Partnering

Patients & Caregiver

Clinical Trials Expanded Access Policy Niemann-Pick Disease Type C Urea Cycle Disorders Vascular Ehlers-Danlos

Our Products

MIPLYFFA® OLPRUVA®

Our Pipeline

Pipeline Clinical Trials Publications & Presentations Medical Literature Medical Information Investigator-Initiated Studies

Careers

Culture Job Openings

Investors

Investor Relations Events & Presentations Stock Quote & Chart Press Releases Corporate Governance Financials State Compliance Contact Email Alerts FAQs

Contact info@zevra.com 888.958.1253

© 2026 Zevra Therapeutics.

All rights reserved.

|

Privacy Policy

|

Notice at Collection

|

Your Privacy Choices

|

Terms of Use

Search Investors

Search this site